173 related articles for article (PubMed ID: 11200968)
1. Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.
Little MP; Deltour I; Richardson S
Radiat Environ Biophys; 2000 Dec; 39(4):241-52. PubMed ID: 11200968
[TBL] [Abstract][Full Text] [Related]
2. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
3. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
Little MP; Hoel DG; Molitor J; Boice JD; Wakeford R; Muirhead CR
Radiat Res; 2008 Jun; 169(6):660-76. PubMed ID: 18494541
[TBL] [Abstract][Full Text] [Related]
4. Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold.
Little MP; Muirhead CR
Int J Radiat Biol; 1998 Oct; 74(4):471-80. PubMed ID: 9798958
[TBL] [Abstract][Full Text] [Related]
5. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
6. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
7. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
8. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
Little MP
Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
11. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
12. Multi-model inference of adult and childhood leukaemia excess relative risks based on the Japanese A-bomb survivors mortality data (1950-2000).
Walsh L; Kaiser JC
Radiat Environ Biophys; 2011 Mar; 50(1):21-35. PubMed ID: 20931336
[TBL] [Abstract][Full Text] [Related]
13. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
Little MP; Hawkins MM; Charles MW; Hildreth NG
Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
[TBL] [Abstract][Full Text] [Related]
14. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
[TBL] [Abstract][Full Text] [Related]
15. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
16. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
18. Simulation-extrapolation method to address errors in atomic bomb survivor dosimetry on solid cancer and leukaemia mortality risk estimates, 1950-2003.
Allodji RS; Schwartz B; Diallo I; Agbovon C; Laurier D; de Vathaire F
Radiat Environ Biophys; 2015 Aug; 54(3):273-83. PubMed ID: 25894839
[TBL] [Abstract][Full Text] [Related]
19. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
[TBL] [Abstract][Full Text] [Related]
20. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
Little MP
Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]